Julie Cardoso: FDA Clears the First AI-Guided Ultrasound Software for Suspected DVT
Julie Cardoso, Owner and Executive Director of Independent Diagnostic Testing Facility at Universal Ultrasound Diagnostics, shared a post on LinkedIn:
“Huge milestone for our team at ThinkSono: the FDA has granted clearance for ThinkSono Guidance.
It’s the first AI-powered ultrasound guidance software cleared for the evaluation of suspected deep vein thrombosis (DVT).
What this means in practice: a nurse or clinician with 60–90 minutes of training can capture a vascular ultrasound exam at the bedside, guided in real time by our AI, with every exam reviewed remotely by a qualified interpreting physician.
Faster answers for patients, wherever they present.
It took a decade of work, 1,691 patients across 24 study sites, and an incredible team to get here. Proud to be part of it!”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Oct 28, 2026, 03:50ZhiChao (David) Yang: MedicalBench Tests AI in Clinical Reasoning
-
Oct 28, 2026, 03:46Phillip Smith: Strengthening Partnerships and Connections in the Rare Disease and Hemophilia Communities
-
Oct 28, 2026, 03:42Ashley Bradley: Understanding Jalen Hurts’ Diagnosis: DVT and Venous Thromboembolism in Athletes
-
Oct 28, 2026, 03:39Gregory Denomme: Petz and Garratty’s Immune Hemolytic Anemias Third Edition
-
Oct 28, 2026, 03:38Ahmed Alotaibi: Monoclonal Antibodies Challenge Routine Pretransfusion Testing
-
Oct 28, 2026, 03:32Wolfgang Miesbach: Should Prophylaxis in Type 3 VWD Follow the Bleeding Phenotype?
-
Oct 28, 2026, 03:25Owen McCarty: Exploring Platelet Polyphosphates in Coagulation Under Flow
-
Oct 28, 2026, 03:19Arwa Z. Al-Riyami: Key Takeaways from the Blood Conference in Auckland
-
Oct 28, 2026, 03:14Kristopher Jonas: The Ethical Case for Compensated Plasma Donation